Even as deaths decline, the majority of people who need addiction treatment are not receiving it, according to federal figures, and for anyone weighing whether to look for a rehab program now or wait, that gap is the more useful fact.
CDC’s latest provisional release predicts 68,641 drug overdose deaths for the 12 months ending in February 2026, a 12.1% decline from the same period a year earlier. The data was released by the National Vital Statistics System on July 15, 2026.
What the Latest Overdose Data Shows
The decline is real and it is substantial. It also follows two decades of the opposite trend, with overdose deaths rising roughly 520% between 1999 and 2023. The first annual decline in that stretch came between 2022 and 2023, when deaths fell nearly 3%.
Two caveats matter for reading the new number correctly. These are provisional counts, not final ones, and CDC notes that they are adjusted for incomplete reporting but still expected to run low, rising over the months after they are first posted. And every prior estimate gets revised with each monthly release, so figures shift.
For scale, in 2023 roughly 105,000 people died from a drug overdose, about 287 deaths a day. Nearly 80,000 of those, about 76%, involved an opioid, and 69% involved synthetic opioids other than methadone, primarily illegally made fentanyl.
Where the Addiction Treatment Gap Sits
Here is the part that has not moved nearly as fast. In 2023, an estimated 54.2 million Americans aged 12 or older needed addiction treatment in the past year. In that same year, 12.8 million people with a past-year substance use disorder received treatment.
Those two figures come from the National Survey on Drug Use and Health and describe slightly different populations, so they do not divide into a clean percentage. What they establish is the shape of the problem. The number of people who needed care was several times the number who got it.
That gap is the reason the death decline and the access picture have to be read together. Falling mortality does not indicate that treatment has become easier to find, and the data does not say it has.
Missed Chances to Connect People With Care
One CDC finding speaks directly to this. In 2023, across 37 states and the District of Columbia, nearly 3 out of 5 drug overdose deaths involved at least one potential opportunity either to link that person to care before the fatal overdose or to take life-saving action when it happened.
That is a striking figure because it describes contact that already occurred. These were people who, at some point, were in reach.
CDC also reports that someone who has survived one opioid overdose is at higher risk of another, which makes the period after a nonfatal overdose one of the clearest windows for getting into treatment rather than waiting.
Who the Decline Has Not Reached
National averages hide a lot. Between 2022 and 2023, overdose death rates moved in different directions depending on the group.
Rates rose 39% for Native Hawaiian or Other Pacific Islander people, from 18.8 to 26.2 deaths per 100,000, and nearly 3% for non-Hispanic Black people, from 47.5 to 48.9.
Rates fell nearly 8% for non-Hispanic White people, from 35.6 to 33.1. For American Indian and Alaska Native, Hispanic, and Asian people, rates did not change significantly. American Indian and Alaska Native people continued to have the highest rate of any group.
CDC describes these differences as widening. A falling national number can coexist with a rising one in a specific community, which is worth knowing if you are searching for care in a place where things do not feel like they are improving.
What This Means for Treatment Seekers
If you are researching addiction treatment for yourself or someone else, the practical takeaway is that improving national statistics do not reduce the value of acting now.
The treatment gap means demand still outstrips what people are actually receiving, and program availability, waitlists, and insurance acceptance vary widely by location and level of care.
It also means the window after an overdose or a health scare is worth treating as urgent rather than as a reason to wait and see.
And because 47% of 2023 overdose deaths across those reporting states involved both opioids and stimulants, it is worth asking any program directly how it handles more than one substance, since the medication options differ.
Finding the Right Rehab
Concrete next steps when comparing programs:
- Compare rehab centers by level of care, from medical detox through inpatient and outpatient options, rather than starting with facility names
- Ask whether the program offers medication-assisted treatment, which combines FDA-approved medications such as buprenorphine, methadone, or naltrexone with counseling
- Ask how the program treats polysubstance use, particularly opioids combined with stimulants
- Verify insurance coverage for addiction treatment before admission, including what your plan requires for prior authorization and how many days it will approve
- Verify licensing, accreditation, and clinical credentials rather than relying on marketing claims
Rehab.com’s directory lets you compare verified treatment centers by location, level of care, insurance accepted, and specialty program, with transparent scoring that explains how each listing is ranked.
Start with the location and level of care you need. You can also call
800-985-8516
( 
Sponsored Helpline )
to speak with a treatment specialist to determine your options.
